GBIO vs. NVIDIA Corporation
GBIO and NVIDIA Corporation are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| GBIO | NVDA | |
|---|---|---|
| Market Cap | — | $5.54 trillion |
| Revenue (TTM) | $15.27 million | — |
| Net Income (TTM) | $-62,627,000 | — |
GBIO and NVDA split the size & scale factors evenly.
Valuation
| GBIO | NVDA | |
|---|---|---|
| P/E Ratio | 0.63 | — |
GBIO and NVDA split the valuation factors evenly.
Profitability
| GBIO | NVDA | |
|---|---|---|
| Net Margin | -410.13% | — |
| Return on Equity | -123.87% | — |
GBIO and NVDA split the profitability factors evenly.
Dividend
| GBIO | NVDA | |
|---|---|---|
| Dividend Yield | — | 0.44% |
GBIO and NVDA split the dividend factors evenly.
Risk & Sentiment
| GBIO | NVDA | |
|---|---|---|
| Short Interest | — | 0.07% |
GBIO and NVDA split the risk & sentiment factors evenly.
Dig deeper: GBIO overview, GBIO financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.